Source: International Congress 2017 – COPD: latest insights into the management of patients
Disease area: Airway diseases



Rating:

Share or cite this content

Citations should be made in the following way:
M. Han (Ann Arbor, United States of America). Frequency of exacerbations in patients with COPD: an analysis of the SPIROMICS cohort. International Congress 2017 – COPD: latest insights into the management of patients

Member's Comments

No comment yet.

Related content which might interest you: Clinical characteristics of patients with frequent COPD exacerbations in a Swiss multicenter COPD cohort study (TOPDOCS) Source: International Congress 2016 – Targeting care, pulmonary rehabilitation, management, and self-management of COPD exacerbations in primary care Year: 2016 COPD in the time of COVID-19: an analysis of acute exacerbations and reported behavioural changes in patients with COPD Source: ERJ Open Res, 7 (1) 00718-2020; 10.1183/23120541.00718-2020 Year: 2021 A global survey conducted to determine frequency of exacerbations in COPD patients Source: Annual Congress 2013 –COPD treatment Year: 2013 Influence of the seasons on exacerbation characteristics in a cohort of COPD patients (EXACO study) Source: Annual Congress 2013 –Factors associated with outcomes in COPD Year: 2013 Persistence of clinical criteria of chronic bronchitis in patients with COPD over time: A longitudinal analysis of the TRACE cohort. Source: International Congress 2017 – Markers of COPD progression Year: 2017 Variability in exacerbation frequency in COPD patients Source: Eur Respir J 2002; 20: Suppl. 38, 264s Year: 2002 Frequency and impact of bronchiectasis in a cohort of patients in a COPD clinic Source: International Congress 2017 – Highlights on clinical problems in COPD Year: 2017 The impact of bronchiectasis on outcomes in a large cohort of patients hospitalised with exacerbations of COPD Source: Annual Congress 2013 –Treating bronchiectasis in respiratory patients Year: 2013 Measuring exacerbations in subjects with mild to moderate COPD from a population-based cohort: The CanCOLD study Source: Annual Congress 2013 –Factors associated with outcomes in COPD Year: 2013 A retrospective cohort study demonstrating the impact of an OPEP device on exacerbations in COPD patients with chronic bronchitis Source: International Congress 2016 – Hospitalisation and comorbidities in chronic lung diseases Year: 2016 Survival in COPD patients with hospitalization due to exacerbation Source: International Congress 2014 – Longitudinal studies of respiratory disease Year: 2014 Analysis of the frequency of COPD exacerbations in the ’real-life’ DACCORD study over a 2 year period Source: International Congress 2016 – Comorbidities and exacerbations in COPD Year: 2016 Analysis of the causes for the frequent exacerbations and hospitalisations in patients with COPD Source: Annual Congress 2009 - Exacerbations of COPD and bronchiectasis: aetiology and treatment Year: 2009 Characterization of readmissions in patients hospitalized with COPD exacerbation Source: International Congress 2016 – Novel avenues in the treatment of COPD II Year: 2016 COPD exacerbations occur more frequently in women – Data from the Bergmannsheil cohort Source: International Congress 2015 – Asthma and COPD: overlap and exacerbations Year: 2015 Characteristics of COPD patients with repeated exacerbations: preliminary results from the PRE-SPIRO survey Source: Annual Congress 2008 - COPD epidemiology Year: 2008 Risk factors for another hospitalization in COPD patients hospitalized for exacerbation Source: International Congress 2016 – Hospitalisation and comorbidities in chronic lung diseases Year: 2016 Interferon-lambda-genotype GG and IgG2 are predictors for frequent COPD exacerbations in a Swiss multicenter COPD cohort study (TOPDOCS) Source: International Congress 2016 – How the understanding og molecular and genomic crosstalk is helping to diagnose lung disease Year: 2016 The cost analysis of our COPD patients Source: Eur Respir J 2006; 28: Suppl. 50, 38s Year: 2006 Prediction models for exacerbations in patients with COPD Source: Eur Respir Rev 2017; 26: 160061 Year: 2017